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Abstract :                                                                                                                                                                    
   
  Lactoferrin is a multifunctional iron-binding protein present in several mucosal secretions as well as in 
secondary granules of polymorphonuclear leukocytes. Anti-lactoferrin antibodies, which belong to anti 
neutrophil cytoplasmic antibodies have been described in several immunomediated diseases.  
A total of 60 nodular and multi-nodular goiter patients, their age ranged from (22-71) years, attending the 
Medical City\Surgery department and Dijlah Private Hospital, during the period from August 2010 -April 2011. 
In addition, twenty healthy (controls), matched patients for age, were also included in the study. The study was 
conducted for the detection of serum level of anti- lactoferrin antibodies by using immunometric enzyme 
immunoassay. While (ADA) enzyme activity was measured by the method of (Giusti, 1981), also Protein ratio 
was measured by the method of (Bradford, 1976).   
 Anti- lactoferrin antibodies were detected in 14 (23.33%) patients, which was significantly higher than that in 
normal individuals (p value 0.01) and the mean of positive cases was (4.473 ± 0.206) compared to the  negative 
cases which was (23.676 ± 2.137) (P value 0.001). (ADA) enzyme showed an increasing in mean value (4.56
A 
± 
1.27) in patients, compared to controls (1.18 
B
 ± 0.49). Total protein was detecting with high values and 
significant difference between patients (21.99
B 
± 0.33 gm/100ml) and control group (8.37
A 
± 1.31 gm/100ml). 
Where the normal value of the total protein is (6.4–8.3) gram per deciliter (g/dL). We conclude that anti-
lactoferrin antibodies could be detected in patients with thyroiditis (single and multiple nodule goiters) in 
addition to elevatet level of  (ADA) enzyme and often total protein in the same patients. 
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Introduction:  
 
  Nodular goiters are clinically recognizable enlargements of the thyroid gland characterized by excessive 
growth and structural and/or functional transformation of one or several areas within the normal thyroid tissue. 
In the absence of thyroid dysfunction, autoimmune thyroid disease, thyroiditis, and thyroid malignancy, they 
constitute an entity described as simple nodular goiter (1). Over the past few decades, clinical and mechanistic 
studies have indicated many relations between nutrition and health, thus evidence that diet is a key 
environmental factor affecting the incidence of many chronic diseases is overwhelming (2),(3). Indeed, several 
food derived compounds we eat are among the most promising chemo-preventive agents being evaluated. 
Chemo-prevention is defined as using chemicals with the goal of preventing, interrupting or reversing the 
carcinogenic process. Since carcinogenesis is a multistage process, which usually takes many years in humans, 
there is ample opportunity to intervene and prevent the development of cancer (4). Cancer is a major killer in 
today's world accounting for around 13% of all deaths according to the World Health Organization (W.H.O.). 
  A promising field of research is clinical studies with cancer preventive proteins existing in milk (5), namely 
lactoferrin (LF). It is a natural forming iron-binding glycoprotein, and known for its inhibitory action on cell 
proliferation, as well as for its anti-inflammatory and antioxidant abilities, has been described to have anti-
carcinogenic properties in several in vivo and in vitro studies (5), (6), (7), (8), (9).  
 LF is produced in exocrine glands located in the gateways of the digestive, respiratory, and reproductive 
systems, and is secreted in many external fluids as a first line of defense. LF also resides in the specific granules 
of polymorph nuclear neutrophil leukocytes (PMN) and becomes exocytose upon PMN activation. During active 
inflammatory disease, raised serum levels of (LF) can be measured (10). Several physiological roles have been 
attributed to LF, namely regulation of iron homeostasis, host defense against infection and inflammation, 
regulation of cellular growth, and differentiation and protection against cancer development and metastasis by 
inducing apoptosis and inhibit proliferation in cancer cells as well as restore white and red blood cell levels after 
chemotherapy. These findings have suggested LF's great potential therapeutic use in cancer disease prevention 
and/or treatment, namely as a chemo preventive agent (11), (12). So LF is a multifunctional protein and an 
essential element of innate immunity.  
  LF participates in acquisition of iron from food and its storage in the body, and to a certain degree also in iron 
transport to cells and the effect of LF in combating microorganisms by chelating iron. The iron-chelating 
property of LF renders iron inaccessible to the pathogens, thus restricting their growth. Iron, due to its 
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participation in many metabolic processes, is an essential element for almost all microorganisms. Iron is not 
easily accessible for pathogens within the host. Since iron is crucial for normal function of both pathogens and 
the host, an ability to acquire iron during infection is regarded as an important virulence factor. Higher 
vertebrates have evolved a complicated protection system of iron storage and LF is an important element of this 
system. Low iron-saturated LF effectively combats bacteria and fungi, acting in a bacteri static and fungi static 
way. The degree of iron saturation also influences antiviral activity of LF. 
 
Adenosine deaminase (also known as adenosine aminohydrolase, or (ADA) is an enzyme (EC 3.5.4.4) involved 
in purine metabolism. It is needed for the breakdown of adenosine from food and for the turnover of nucleic 
acids in tissues (13), the enzyme has been found in bacteria, plants, invertebrates, vertebrates, and mammals, 
with high conservation of amino acid sequence (14). Primarily, ADA in humans is involved in the development 
and maintenance of the immune system. However, ADA association has also been observed with epithelial cell 
differentiation, neurotransmission, and gestation maintenance (15). It has also been proposed that ADA, in 
addition to adenosine breakdown, stimulates release of excitatory amino acids and is necessary to the coupling of 
A1 adenosine receptors and heterotrimeric G proteins (16). There are 2 isoforms of ADA: ADA1 and ADA2. 
ADA1 is found in most body cells, particularly lymphocytes and macrophages, where it is present not only in the 
cytosol and nucleus but also as the ecto- form on the cell membrane attached to dipeptidyl peptidase-4 (aka, 
CD26). ADA2 was first identified in human spleen (17). It was subsequently found in other tissues including the 
macrophage where it co-exists with ADA1. The two isoforms regulate the ratio of adenosine to deoxyadenosine 
potentiating the killing of parasites. ADA2 is the predominant form present in human blood plasma and is 
increased in many diseases, particularly those associated with the immune system: for example rheumatoid 
arthritis, psoriasis and sarcoidosis. The plasma ADA2 isoform is also increased in most cancers. ADA2 is not 
ubiquitous but co-exists with ADA1 only in monocytes-macrophages (18). Deficient levels of ADA have also 
been associated with pulmonary inflammation, thymic cell death, and defective T-cell receptor signaling (19). 
 Cancer is a complex disease that is dictated by both cancer cell-intrinsic and cell-extrinsic processes. Adenosine 
is an ancient extracellular signaling molecule that can regulate almost all aspects of tissue function. As such, 
several studies have recently highlighted a crucial role for adenosine signalling in regulating the various aspects 
of cell-intrinsic and cell-extrinsic processes of cancer development (19). Accordingly, the present study was 
designed to inspect the role of ADA enzyme in this type of goiter as well as lactoferrin.                                         
                                                   
    
Subjects, Material and Methods: 
 
Subjects: 
 
  This study includes sixty nodular and multi-nodular goiter patients attending the Medical City\Surgery 
department and Dijlah Private Hospital, during the period from August 2010 -April 2011. 
They were clinically examined and evaluated by the consultant medical staff at the two hospitals and they were 
subjected to a personal interview and full history was taken including age, disease history in the family, other 
associated disease and drug intake. The result of neck scan, analysis of thyroid hormone, clinical feature, were 
taken from the case sheet. All patients were investigated in teaching laboratories of medical city /immunology 
department. In addition, twenty healthy (controls), matched patients for age, were also included in the study. 
 
Blood Collection: 
 
  Five milliliter (ml) of venous blood was collected from each patient. Sera were separated after leaving the 
sample at room temperature for about 15-30 minutes, and then centrifuged at 1500 rpm (revolution per minute) 
for 5 minute, serum were dispensed into 4-5 Eppendrof tubes, frozen at -20°C, and were used for assessment of 
(LF), (ADA) enzyme and specific protein. 
 
 
Serum Level of Anti-Lactoferrin Antibodies:  
 
  By using immunometric enzyme immunoassay for quantitative determination of auto antibodies against 
lactoferrin  (20). 
Highly purified lactoferrin is bound to micro wells. Antibodies against this antigen, is present in diluted serum or 
plasma, bind to the respective antigen. Washing of the micro wells removes unspecific serum and plasma 
components. Horseradish peroxidease (HRP) conjugate anti-human IgG immunologically detects the bound 
patient antibodies forming a conjugate/antibody/antigen complex. Washing of the micro wells removes unbound 
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conjugate. An enzyme substrate in the presence of bound conjugate hydrolysis to form a blue color. The addition 
of an acid stops the reaction forming a yellow end-product. The intensity of this yellow color is measured photo 
metrically at 450 nm. The intensity of color is directly proportional to the concentration of IgG antibodies 
present in the original sample. 
 
Calculation of Sample Results: 
 
The sample results were calculated by interpolation from a standard curve that was performed in the same assay 
as that for samples by using standard curve fitting equations for anti-lactoferrin (Figure -1). 
 
Assessment of ADA enzyme: 
  
(ADA) enzyme activity was measured by the method of (Giusti, 1981). This method depending on an indirect 
measurement of ammonia production when (ADA) enzyme acting on adenosine. 
Ammonia forms an intensely blue indophenols with sodium hypochlorite and phenol in alkaline solution, 
ammonia concentration is directly proportional to the absorbance of the indophenols at 630nm (21).  
 
Estimation of Total Protein: 
 
Protein ratio was measured by the method of (Bradford, 1976). Using (Biurate)  solution. This method 
depending on the direct interaction of carbomyl group in proteins with alkaline cupper solution to configure a 
purple compound which was spectro photo metrically assessed at 540 nm (22) . 
 
Statistical Analysis: 
 
  The Statistical Analysis System- SAS (2010) was used to effect of different factors in study parameters. The 
student T test and Chi-square test was used to compare the level among patients and control group. Duncan 
multiple range test was used to significant compare between means in this study.  
 
Results:  
 
 The study involved sixty nodular and multi- nodular goiter patients. Their age ranged from (22-71) years. A 
twenty healthy individuals matched group served as control.  
 
  Anti- Lactoferrin   Ab. In nodular and multi- nodular goiter patients:  
  
We analyzed the prevalence of anti-lactoferrin antibodies in a number of patients with thyroiditis (single and 
multiple nodule goiters) Iraqi Patients. The main clinical and immunological features of the patients are reported 
in table 1, table 2 and figure 2. 
Lactoferrin antibodies were elevated above normal level (10 U/ml) in 14 (23.33%) patients, which was 
significantly higher than that in normal individuals (p value 0.01) and the mean of positive cases was (4.473 ± 
0.206) compared to the  negative cases which was (23.676 ± 2.137) (P value 0.001) table1. 
 
(ADA) enzyme in nodular and multi- nodular goiter patients with control:   
 
 Our results revealed that there are elevation in (ADA) enzyme and also total protein in serum of (single and 
multiple nodule goiters) Iraqi patients as compared with control group. Table 3, showed an increased in mean 
value of (ADA) enzyme (4.56
A 
± 1.27) in patients, compared to controls (1.18 
B
 ± 0.49).  
 
 Total Protein in nodular and multi- nodular goiter patients with control:  
 
The table 4, showed high values of total protein with significant difference between patients (21.99
B 
± 0.33 
gm/100ml) and control group (8.37
A 
± 1.31 gm/100ml). 
                                                                                               
Discussion:   
 
As in table1, table 2 and figure 2, lactoferrin antibodies were elevated above normal level (10 U/ml) in 14 
(23.33%) patients, which was significantly higher than that in normal individuals (p value 0.01) and the mean of 
positive cases was (4.473 ± 0.206) compared to the negative cases which was (23.676 ± 2.137) (P value 0.001). 
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Elevated levels of lactoferrin antibodies based on molecular science that have shown that lactoferrin is 
multitasking protein, exhibit antibacterial, antiviral, anti inflammatory activity and that anti-LF antibodies 
binding to LF block the anti-inflammatory activity of it, which implies a deterioration in host defense against 
microorganisms and inflammation (23). Such findings agree with the findings of investigators that lactoferrin 
immune reactivity was strongly associated with neoplastic proliferation and may be used as a useful auxiliary 
marker to distinguish malignant from benign thyroid lesions in cytological smears and biopsy samples (24).  
  In another Immuno histochemical study of lactoferrin in follicular adenomas and thyroid carcinomas, follicular 
adenomas showed a consistent negativity, whereas follicular and papillary carcinomas exhibited various degrees 
of positivity for lactoferrin. Incorporated organoid structures observed in anaplastic carcinomas were strongly 
stained; the spindle cell parts of these cancers were always negative for this iron-binding protein. Medullary 
carcinomas were also unstained (25). Due to its iron binding properties and interactions with target cells and 
molecules, lactoferrin can both positively and negatively influence immune system cells and cells involved in the 
inflammation reaction. In one way, lactoferrin may support the proliferation, differentiation, and activation of 
immune system cells and strengthen the immune response. On the other hand, lactoferrin acts as an anti-
inflammatory factor. Thanks to its antimicrobial activity and capability of binding components of bacterial cell 
walls (LPS) or their receptors, lactoferrin may prevent the development of inflammation and subsequent tissue 
damage caused by the release of pro-inflammatory cytokines and reactive oxygen species (26). The protective 
effect of lactoferrin is manifested in a reduced production of some pro-inflammatory cytokines such as tumor 
necrosis factor (TNF α) or interleukins IL-1β and IL-6 (27), (28).  
Our results revealed that there are elevation in (ADA) enzyme in serum of (single and multiple nodule goiters) 
patients as compared with control group. Table 3, showed an increased in mean value of (ADA) enzyme (4.56
A 
± 
1.27) in patients, compared to controls (1.18 
B
 ± 0.49).In a study of Roberts EL and Roberts OT , 2012, in which 
paid study on patients with different tumors, Plasma AD2 was measured before and seven to 10 days after the 
first dose of chemotherapy. The changes in plasma AD2 were then compared with the tumor regression score, 
following first-dose chemotherapy, plasma AD2 was decreased. The percentage decrease in plasma AD2 
correlated with the tumor regression score. These data suggest that plasma AD2 may have a role in determining 
tumor response to treatment (29). Therefore, our results agree with the researchers study that the level of (ADA) 
enzyme was raised and the activity is increased in conditions associated with tumor growth. Such findings may 
highlight the importance of Plasma AD for the screening and monitoring of cancer, as AD2 activity is increased 
in conditions associated with tumor growth. 
Proteins are large, complicated molecules that are vital to the function of all cells and tissues. They are made in 
many places throughout the body and circulate in the blood. Proteins take a variety of forms, such as; albumin, 
antibodies and enzymes and have many different functions including; helping to fight disease, regulating body 
functions, building muscles and transporting drugs and other substances throughout the body and the possible 
causes of high blood protein include: bone marrow disorder and chronic inflammatory conditions. Certain 
proteins in the blood may be elevated as the body fights an infection or some other inflammation (30).  
In many cases, it results from excessive activity of the thyroid gland, with a pathologically increased production 
of thyroid hormones (31). A total serum protein test measures the total amount of protein in the blood. It also 
measures the amounts of two major groups of proteins in the blood: albumin and globulin (32).  The results of 
this study, showed high values of total protein with significant difference between patients (21.99
B 
±0.33 
gm/100ml) and control group (8.37
A 
± 1.31 gm/100ml). Where  the normal value of the total protein is (6.4–8.3) 
gram per deciliter (g/dL), table 4. 
 
Our results, disagree with another study of Al byati, R. K. M. et. al., 2009, on patients with (Breast, Ovary and 
Uterus) cancer, Their results indicated the presence of significant decrease (P<0.05) in albumin concentration in 
uterus cancer patients and in pregnant women and non significant difference (p>0.05) in breast and ovary cancer 
patients as compared to normal subjects, also a non significant difference (p>0.05) in total protein and globulin 
concentrations in all patients groups and pregnant women as compared to normal subjects (33). However there is 
another study support our results that it can be concluded that the total serum protein was higher in female 
patients with breast cancer, compared to the healthy female group and the results of their study indicate that 
serum protein levels may be used for the diagnosis of breast cancer (34). 
 
  This increase in total serum protein concentration can be due to the fact that total serum protein is composed of 
albumin and other proteins, collectively termed as globulins, and it is known that the serum albumin 
concentration may change under oxidative stress, such as the stress associated with cancer (35). In addition, as 
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the plasma circulates through the tissues, it collects proteins that are released from their original locations due to 
certain physiological events, including tissue remodeling, trauma and cell death, which lead to an increase in 
total serum protein (36).                                                                                                              
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Table 1: Anti-Lactoferrin Ab in In Thyroiditis (single and multiple nodule goiters) Patients  
               Comparison to Healthy Control. 
Study groups                    Anti-Lactoferrin Ab. 
   Positive (≥10U/ml) 
        
  Negative(˂10U/ml) 
          
       No.       %        No.     % 
Thyroiditis (single and multiple 
nodule goiters) 
      14 23.33             46 76.66 
Healthy control         0        0         20   100 
Total         14          66  
P-value       0.01*           
 
Table 2: Mean value of Anti-Lactoferrin Ab in positive and negative Thyroiditis (single and multiple nodule 
               goiters) Patients. 
 
Study groups 
Positive patients Negative patients All patients 
     Mean ± S.E    Mean ± S.E    Mean ± S.E 
    4.473 ± 0.206 23.676 ± 2.137  7.092 ± 0.398 
 P value    0.001*  
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Table 3:  (ADA) enzyme activity in serum of single and multiple nodule goiters patients and control. 
 
      Groups  (ADA) Activity Unit/mg protein 
                   Mean ± SD.   
      Patients                    4.56 
A 
± 1.27 
      Control                    1.18 
B
 ± 0.49 
 Significant differences between groups (P≤ 0.05). 
 
 
 
Table 4: Mean of Total protein value in serum of single and multiple nodule goiters patients and control. 
   
      Groups         Total Protein gm/100ml 
                   Mean ± SD.   
      Patients                   21.99
B 
± 0.33 
      Contrl           8.37 
A  
± 1.31 
 Significant differences between groups (P≤ 0.05). 
 
                  
 
          
 
                       Figure1:  ELISA standard curve of Lactoferrin.  
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                     Figure 2: Lactoferrin concentration in serum of single and multiple nodule goiters patients. 
 
